These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 8472436

  • 1. Chemotherapy for soft-tissue sarcomas.
    Elias AD.
    Clin Orthop Relat Res; 1993 Apr; (289):94-105. PubMed ID: 8472436
    [Abstract] [Full Text] [Related]

  • 2. [Chemotherapy for soft tissue sarcoma--current concepts and review].
    Umeda T, Ishii T, Hatakeyama K, Wakita H.
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1937-44. PubMed ID: 8215466
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant chemotherapy in the treatment of soft-tissue sarcoma.
    Mertens WC, Bramwell VH.
    Clin Orthop Relat Res; 1993 Apr; (289):81-93. PubMed ID: 8472435
    [Abstract] [Full Text] [Related]

  • 4. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
    Schuetze SM, Patel S.
    Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
    [Abstract] [Full Text] [Related]

  • 5. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD, Elias AD.
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
    [Abstract] [Full Text] [Related]

  • 6. [Role of adjuvant chemotherapy in the treatment of soft tissue sarcoma].
    Debled M, Ravaud A, Stöckle E, Nguyen BB.
    Bull Cancer; 1997 Jun; 84(6):653-63. PubMed ID: 9295870
    [Abstract] [Full Text] [Related]

  • 7. Adjuvant chemotherapy for soft tissue sarcomas.
    Mertens WC, Bramwell VH.
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):801-15. PubMed ID: 7490242
    [Abstract] [Full Text] [Related]

  • 8. Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy.
    Bramwell VH.
    Can J Surg; 1988 Nov; 31(6):390-6. PubMed ID: 3052763
    [Abstract] [Full Text] [Related]

  • 9. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials].
    Budach V.
    Strahlenther Onkol; 1996 Jul; 172(7):403-4. PubMed ID: 8693407
    [No Abstract] [Full Text] [Related]

  • 10. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY, European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    J Clin Oncol; 2007 Jul 20; 25(21):3144-50. PubMed ID: 17634494
    [Abstract] [Full Text] [Related]

  • 11. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ, Xu F, Wang SS, Luo HY, Wang F, Li FH, Sun XF, Xu GC, Lin TY, Huang HQ, Jiang WQ, Guan ZZ, Xu RH.
    Ai Zheng; 2007 Dec 20; 26(12):1344-9. PubMed ID: 18076798
    [Abstract] [Full Text] [Related]

  • 12. Systemic adjuvant chemotherapy for soft tissue sarcomas.
    Zalupski MM, Baker LH.
    Hematol Oncol Clin North Am; 1995 Aug 20; 9(4):787-800. PubMed ID: 7490241
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven.
    Blay JY, Le Cesne A.
    Oncologist; 2009 Oct 20; 14(10):1013-20. PubMed ID: 19808771
    [Abstract] [Full Text] [Related]

  • 14. The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas.
    Ferrari A, Brecht IB, Koscielniak E, Casanova M, Scagnellato A, Bisogno G, Alaggio R, Cecchetto G, Catania S, Meazza C, Int-Veen C, Kirsch S, Dantonello T, Carli M, Treuner J.
    Pediatr Blood Cancer; 2005 Aug 20; 45(2):128-34. PubMed ID: 15852434
    [Abstract] [Full Text] [Related]

  • 15. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ, Pujol N, Liénard D, Mosimann F, Raffoul W, Genton A, Guillou L, Landry M, Chassot PG, Chiolero R, Bischof-Delaloye A, Leyvraz S, Mirimanoff RO, Bejkos D, Leyvraz PF.
    Eur J Surg Oncol; 2000 Nov 20; 26(7):669-78. PubMed ID: 11078614
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant chemotherapy for patients with soft tissue sarcoma.
    Ozaki T, Sugihara S, Hamada M, Nakagawa Y, Inoue H.
    Hiroshima J Med Sci; 1993 Sep 20; 42(3):109-15. PubMed ID: 8253605
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant chemotherapy of adult patients with soft tissue sarcomas.
    Rosenberg SA.
    Important Adv Oncol; 1985 Sep 20; ():273-94. PubMed ID: 3916745
    [Abstract] [Full Text] [Related]

  • 18. [Adjuvant chemotherapy in soft-tissue sarcomas?].
    Sauer H.
    Strahlenther Onkol; 1995 Apr 20; 171(4):185-94. PubMed ID: 7740405
    [Abstract] [Full Text] [Related]

  • 19. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
    Tsuchiya H, Tomita K, Yamamoto N, Mori Y, Asada N.
    Anticancer Res; 1998 Apr 20; 18(5B):3651-6. PubMed ID: 9854472
    [Abstract] [Full Text] [Related]

  • 20. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.
    Demetri GD.
    Semin Oncol; 1996 Jun 20; 23(3 Suppl 6):22-6. PubMed ID: 8677444
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.